BioGaia already has agreements with Ferring Pharmaceuticals covering some ten countries in Latin America, where Mexico was the first country to launch the products. In Argentina the regulatory process is expected to be initiated now. The other countries in the region will follow as the regulatory processes in respective countries are finished.
At the same time as the agreement with Ferring Pharmaceuticals for Argentina is signed BioGaia discontinued the agreement relating to Egypt. The agreement was signed in 2008 but due to regulatory difficulties no products have been launched.
Peter Rothschild, president of BioGaia, said: “Latin America is a relatively new market for us and we are looking forward to launching our products in yet another country in this region.”